A new self-attenuated therapeutic influenza vaccine that uses host cell-restricted attenuation by artificial microRNAs

Vector-delivered artificial miRNA effectively inhibited replication of Chikungunya virus

(2016) Amrita Saha et al.   ANTIVIRAL RESEARCH

Identification of Zika Virus and Dengue Virus Dependency Factors using Functional Genomics

(2016) George Savidis et al.   Cell Reports

Generation of a safe and effective live viral vaccine by virus self-attenuation using species-specific artificial microRNA

(2015) Junwei Li et al.   JOURNAL OF CONTROLLED RELEASE

Drug Discovery of Host CLK1 Inhibitors for Influenza Treatment

(2015) Mian Zu et al.   MOLECULES

Vaccines against influenza A viruses in poultry and swine: Status and future developments

(2015) J. Rahn et al.   VACCINE

Inhibition of Dengue Virus 2 Replication by Artificial MicroRNAs Targeting the Conserved Regions

(2015) Pei-wen Xie et al.   Nucleic Acid Therapeutics

Targeted Silencing of Anthrax Toxin Receptors Protects against Anthrax Toxins

(2014) Maria T. Arévalo et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Influenza Viruses and mRNA Splicing: Doing More with Less

(2014) J. Dubois et al.   mBio

Artificial microRNAs can effectively inhibit replication of Venezuelan equine encephalitis virus

(2013) Manish Bhomia et al.   ANTIVIRAL RESEARCH

A Versatile RNA Vector for Delivery of Coding and Noncoding RNAs

(2013) S. Schmid et al.   JOURNAL OF VIROLOGY

Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010

(2012) Rafael Lozano et al.   LANCET

Comparison of antibody and T-cell responses elicited by licensed inactivated- and live-attenuated influenza vaccines against H3N2 hemagglutinin

(2011) Saleem Basha et al.   HUMAN IMMUNOLOGY

Live and Inactivated Influenza Vaccines Induce Similar Humoral Responses, but Only Live Vaccines Induce Diverse T-Cell Responses in Young Children

(2011) Daniel F. Hoft et al.   JOURNAL OF INFECTIOUS DISEASES

High dose and low dose Lactobacillus acidophilus exerted differential immune modulating effects on T cell immune responses induced by an oral human rotavirus vaccine in gnotobiotic pigs

(2011) Ke Wen et al.   VACCINE

Antivirals and resistance: influenza virus

(2011) Michael G Ison   Current Opinion in Virology

Genome-wide RNAi screen identifies human host factors crucial for influenza virus replication

(2010) Alexander Karlas et al.   NATURE

Longitudinal 2 years field study of conventional vaccination against highly pathogenic avian influenza H5N1 in layer hens

(2010) Miriam Rudolf et al.   VACCINE

Inhibition of rabies virus replication by multiple artificial microRNAs

(2009) Nipan Israsena et al.   ANTIVIRAL RESEARCH

A Physical and Regulatory Map of Host-Influenza Interactions Reveals Pathways in H1N1 Infection

(2009) Sagi D. Shapira et al.   CELL

The IFITM Proteins Mediate Cellular Resistance to Influenza A H1N1 Virus, West Nile Virus, and Dengue Virus

(2009) Abraham L. Brass et al.   CELL

Human host factors required for influenza virus replication

(2009) Renate König et al.   NATURE

MicroRNA-mediated species-specific attenuation of influenza A virus

(2009) Jasmine T Perez et al.   NATURE BIOTECHNOLOGY

The potential impact of neuraminidase inhibitor resistant influenza

(2008) Angie Lackenby et al.   CURRENT OPINION IN INFECTIOUS DISEASES

Most mammalian mRNAs are conserved targets of microRNAs

(2008) R. C. Friedman et al.   GENOME RESEARCH

Artificial MicroRNAs as siRNA Shuttles: Improved Safety as Compared to shRNAs In vitro and In vivo

(2008) Ryan L Boudreau et al.   MOLECULAR THERAPY

Drosophila RNAi screen identifies host genes important for influenza virus replication

(2008) Linhui Hao et al.   NATURE

Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?

(2008) Witold Filipowicz et al.   NATURE REVIEWS GENETICS

Identification of Host Proteins Required for HIV Infection Through a Functional Genomic Screen

(2008) Abraham L. Brass et al.   SCIENCE